Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion - Reuters
- Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion Reuters
- Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro CNBC
- Eli Lilly's GLP-1 demand drives up stock price post-Q1 results Yahoo Finance
- Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum | Eli Lilly and Company Investors | Eli Lilly and Company
- Lilly Touts 26% Q1 Revenue Growth on Strong Mounjaro Sales, Raises Full-Year Guidance by $2B BioSpace